Modified-release magnesium attenuates premenstrual symptoms

By  

Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Pilot Study of Relative Bioavailability of Two Oral Formulations of Ketoprofen 25 mg in Healthy Subjects. A Fast-Dissolving Lyophilized Tablet as Compared to Immediate Release Tablet

By Ahmed I. S.   Fatahalla F. A.  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 5, 2007-05 ,pp. : 505-511

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of the Treatment of Infectious Diarrhoea with Non-Absorbable Rifamycin SV Formulated as MMX Modified Release Tablet vs. Rifaximin

By Stefano A.F.D. Di   Binelli D.   Labuschagne W.   Mojapelo M.   Walt E. van der   Patel S.   Moro L.  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 192-203

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of the Treatment of Infectious Diarrhoea with Non-Absorbable Rifamycin SV Formulated as MMX Modified Release Tablet vs. Rifaximin

By  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 192-203

Bentham Science Publishers

Access to resources Recommend Favorite

A naturalistic study of paroxetine in premenstrual syndrome: - efficacy and side-effects during ten cycles of treatment

By Sundblad C.   Wikander I.   Andersch B.   Eriksson E.  

European Neuropsychopharmacology, Vol. 7, Iss. 3, 1997-08 ,pp. : 201-206

Elsevier

Access to resources Recommend Favorite